✦ LIBER ✦

Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation

✍ Scribed by Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Effectiveness of Dabigatran,

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB

Outcomes of Discontinuing Rivaroxaban Co

✍ Patel, Manesh R.; Hellkamp, Anne S.; Lokhnygina, Yuliya; Piccini, Jonathan P.; Z 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Real-world comparative effectiveness and

✍ Laliberté, François; Cloutier, Michel; Nelson, Winnie W.; Coleman, Craig I.; Pil 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 422 KB

Real-World Comparative Effectiveness And

✍ Laliberté, F.; Cloutier, M.; Nelson, W.W.; Coleman, C.I.; Pilon, D.; Olson, W.H. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Stroke prevention in patients with atria

✍ Lanitis, T.; Cotté, F. E.; Gaudin, A. F.; Kachaner, I.; Kongnakorn, T.; Durand-Z 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 611 KB

Economic Evaluation of Warfarin, Dabigat

✍ Wisløff, Torbjørn; Hagen, Gunhild; Klemp, Marianne 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 765 KB